Survey: 77% of US Adults Support Vaccines, But Many Unclear on Which Ones
September 29, 2026 — NFID survey: 77% of US adults support vaccines, but only 48% got respiratory vaccines. Learn about the knowledge gap and how to improve uptake.
Curated Health Wellness News
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
Nanox.AI Expands UK Reach with Vertec Deal, Intel Optimization
September 29, 2026 — Nanox.AI signs exclusive UK reseller deal with Vertec Scientific for HealthOST bone solution and partners with Intel to optimize on-device AI inference for medical imaging.
Nutriband CEO Featured in Opioid Crisis Documentary
September 29, 2026 — Nutriband CEO Gareth Sheridan discusses the opioid crisis and AVERSA abuse-deterrent tech in a new documentary. Learn how NTRB is innovating safer transdermal patches.
NanoViricides Advances NV-387 with Phase II Trials for Mpox and Ebola
September 29, 2026 — NanoViricides reports fiscal 2026 results: NV-387 gains approval for Phase II trials in DRC for Mpox and Ebola, plus FDA designations for measles. Read more.
GeoVax Highlights CDC Report on Sustained Clade Ib Mpox Transmission in U.S.
September 29, 2026 — GeoVax highlights CDC's report of sustained Clade Ib mpox transmission in the U.S. and advances GEO-MVA vaccine to Phase 3, emphasizing preparedness and vaccine supply.
Wolfson Group Champions the Multi-Category Wellness Consumer
September 29, 2026 — Wolfson Group spotlights the multi-category wellness consumer, spanning weight, cognition, gut health, and aging. See how its brands adapt to holistic wellness.
AgeReverse Expands to U.S. with Multi-Hallmark Longevity Supplement
September 29, 2026 — AgeReverse expands to U.S. with RESURGE, a supplement targeting all 12 hallmarks of aging. Market projected to hit $5.98B by 2034 as demand for multi-ingredient longevity products grows.
Anne Therese Aesthetic Medicine Offers Non-Surgical Skin and Body Treatments in Cape Coral
September 29, 2026 — Anne Therese Aesthetic Medicine offers IPL/BBL Photofacial and CoolSculpting Elite in Cape Coral. Personalized plans for sun damage and fat reduction. Book a consultation.
Neurosurgeon Avery Buchholz Named 2026 Castle Connolly Top Doctor
September 29, 2026 — Avery L. Buchholz, MD, FAANS, named 2026 Castle Connolly Top Doctor for third year. Board-certified neurosurgeon at Capital Spine and Pain Institute.
Laser Center of Marin Urges Early Fall Booking for Holiday Injectables
September 29, 2026 — Laser Center of Marin advises booking injectable and laser treatments early this fall for optimal holiday results. Physician-supervised care in Corte Madera, CA.
Helix BioPharma Strengthens Board with Four New Directors
September 28, 2026 — Helix BioPharma appoints four new directors to its Board, strengthening governance and expertise in biotech, finance, and clinical development. Learn more.
Viromed Advances Cold Plasma Products, Confirms 2026 Guidance
September 28, 2026 — Viromed Medical AG reports H1 2026 progress: cold plasma pipeline, ViroCAP® med approval, revenue up to €2.5M, and confirms full-year guidance.
Novogenia AG Reports H1 2026 Results, Advances Personalized Health Growth
September 28, 2026 — Novogenia AG H1 2026 report: revenue EUR 25.7M, DNA analysis growth, cost cuts, strategic partnerships, and global expansion in personalized health.
Redcare Pharmacy Raises 2026 Guidance on Strong Rx Momentum
September 28, 2026 — Redcare Pharmacy raises FY2026 revenue guidance again, driven by strong Rx momentum in Germany. Rx revenue now expected at EUR 730-760M, total growth 16-18%.
Nanox Tackles Global Imaging Gap with Integrated 3D Diagnostics Platform
September 28, 2026 — Nanox integrates FDA-cleared 3D tomosynthesis to expand imaging access. With $4.2M Q2 revenue, it targets global disparities in radiology.
Regentis Biomaterials Leads Shift to Structural Knee Cartilage Repair
September 28, 2026 — Regentis Biomaterials' GelrinC hydrogel implant shows 100% greater KOOS improvement than microfracture, targeting early knee cartilage repair. CE Marked in Europe, U.S. trials underway.
Regentis Biomaterials Leads Shift to Structural Knee Cartilage Repair
September 28, 2026 — Regentis Biomaterials advances GelrinC, a cell-free hydrogel implant for knee cartilage repair, shifting from symptom management to structural intervention. CE Mark approved, U.S. trial enrollment targeted for 2026.
BioMedWire Highlights Glioblastoma Research and CNS Pharmaceuticals
September 28, 2026 — BioMedWire highlights glioblastoma research and CNS Pharmaceuticals' drug development efforts. Learn about the fight against this deadly brain cancer and the latest breakthroughs.
Stacey Eisenberg Named Finalist for 2026 Austin Business Woman Award
September 28, 2026 — Stacey Eisenberg of A Place At Home - North Austin is a finalist for the 2026 Austin Business Woman Health Expert award. Learn about her impact in home care.
NanoViricides Begins Phase II Trial of NV-387 for Ebola in DRC
September 28, 2026 — NanoViricides starts Phase II trial of NV-387 oral gummies for Ebola in DRC. The trial aims to establish dosing and evaluate effectiveness against Bundibugyo Ebolavirus.